today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in gastric cancer patients with MET amplification. This clinical trial is a single ...

This clinical trial is a single-arm, multi-center, open-label, Phase II registration study to evaluate the efficacy, safety and tolerability of savolitinib in treating gastric cancer or ...

The multitude and diversity of mutations detected in similar cancers affecting the same tissue greatly complicates this rational target selection for a broad patient population. This observation ...

If you are developing a production application, we recommend using TypeScript and enable type-aware lint rules. Check out the TS template to integrate TypeScript and typescript-eslint in your project.

User fills out the registration form. System validates the data. System sends verification code by e-mail. System validates the code. System saves the user in the ...

There is no evidence evaluating efficiency, effectiveness, and safety outcomes in older patients in the context of pulsed‐field ablation technology for the ablation of atrial fibrillation. We aimed to ...

Patients who met the criteria were randomly assigned at a 1:1 ratio to receive argatroban plus DAPT or DAPT alone (Figure 1). A simple randomization method was used, utilizing a computer-generated ...

Trial registration number NCT00000608 ... Participants were not notified of their assigned dietary pattern or sodium sequence. During feeding periods (run-in and intervention), participants were ...